Results of a safety, tolerability and pharmacokinetic phase I study of VCH-916, a novel polymerase inhibitor for HCV, following single ascending doses in healthy volunteers

被引：4
|
作者：
Proulx, L. [1 ]
Bourgault, B. [1 ]
Chauret, N. [1 ]
Larouche, R. [2 ]
Tanguay, M. [2 ]
Thibert, R. [1 ]
机构：
[1] ViroChem Pharma Inc, Laval, PQ, Canada
[2] Anapharm A PharmaNet Co, Montreal, PQ, Canada
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60856-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
854
引用
收藏
页码：S320 / S321
页数：2
相关论文
共 50 条
  • [11] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV NS5A INHIBITOR ABT-267 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY ADULT VOLUNTEERS
    Dumas, E. O.
    Lawal, A.
    Menon, R. M.
    Podsadecki, T.
    Awni, W.
    Dutta, S.
    Williams, L.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S475 - S476
  • [12] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV POLYMERASE INHIBITOR ABT-333 FOLLOWING MULTIPLE ASCENDING DOSES AND EFFECT OF CO-ADMINISTRATION OF KETOCONAZOLE IN HEALTHY SUBJECTS
    Menon, R.
    Cohen, D.
    Nada, A.
    Chiu, Y. -L.
    Podsadecki, T.
    Awni, W.
    Bernstein, B.
    Klein, C.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S348 - S348
  • [13] SAFETY, TOLERABILITY AND PHARMACOKINETIC OF GIC-1001 FOLLOWING MULTIPLE ASCENDING DOSES ADMINISTRATIONS THROUGH AN ADAPTIVE FIRST IN HUMAN STUDY IN HEALTHY VOLUNTEERS.
    Paquette, J. M.
    Rufiange, M.
    Sadoune, A. Ait
    Sicard, E.
    Massicotte, J.
    Lefebvre, M.
    Colin, P.
    Ranger, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S61 - S61
  • [14] Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers
    Ino, Hiroko
    Endo, Akira
    Wakamatsu, Akira
    Ogura, Hirofumi
    Numachi, Yotaro
    Kendrick, Stuart
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 70 - 77
  • [15] A single ascending-dose study of mirogabalin in healthy subjects: safety, tolerability, pharmacokinetic, and pharmacodynamic results
    Brown, K.
    Ohwada, S.
    Warren, V.
    Zahir, H.
    Dishy, V.
    JOURNAL OF PAIN, 2016, 17 (04): : S76 - S76
  • [16] Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects
    Denning, Jill
    Cornpropst, Melanie
    Flach, Stephen D.
    Berrey, Michelle M.
    Symonds, William T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) : 1201 - 1208
  • [17] Phase I safety and pharmacokinetic study of magnesium isoglycyrrhizinate after single and multiple intravenous doses in Chinese healthy volunteers
    Sun, Li
    Shen, Jinfang
    Pang, Xiaoyun
    Lu, Lungen
    Mao, Yimin
    Zeng, Minde
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (06): : 767 - 773
  • [18] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RG1678. A NOVEL GLYCINE REUPTAKE INHIBITOR: A SINGLE ASCENDING DOSE STUDY IN HEALTHY VOLUNTEERS.
    Martin-Facklam, M.
    Hofmann, C.
    Banken, L.
    Alberati, D.
    Schmitt, G.
    Parrott, N.
    Hainzl, D.
    Robson, R.
    Nave, S.
    Boutouyrie, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S57 - S57
  • [19] Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies
    Fuertig, Rene
    Goettel, Markus
    Herich, Lena
    Hoefler, Josef
    Wiebe, Sabrina T.
    Sharma, Vikas
    CNS DRUGS, 2023, 37 (12) : 1081 - 1097
  • [20] Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies
    René Fuertig
    Markus Goettel
    Lena Herich
    Josef Hoefler
    Sabrina T. Wiebe
    Vikas Sharma
    CNS Drugs, 2023, 37 : 1081 - 1097
12345